Page 5 - Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Nov 23, 2025

Discover large cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

119 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1228
CANbridge Pharmaceuticals
HK$1.95-6.3%1,217.6%HK$996.1mn/aPS14.5xn/an/a
950
Lee's Pharmaceutical Holdings
HK$1.69-6.1%44.4%HK$995.1mn/aPE10.2xn/a2.8%
9939
Kintor Pharmaceutical
HK$2.01-6.9%89.6%HK$930.7mn/aPS77.3xn/an/a
2257
Sirnaomics
HK$8.00-6.9%216.2%HK$843.2mHK$72.10PS114.2xS52.0%n/a
239
Pak Fah Yeow International
HK$2.40-2.0%0%HK$747.9mn/aPE10.5xn/a7.7%
690
Uni-Bio Science Group
HK$0.12-3.3%85.7%HK$698.6mn/aPE7.6xn/a2.4%
2563
Beijing Biostar Pharmaceuticals
HK$3.10-0.6%-89.3%HK$671.8mn/aPS11.5xn/an/a
1652
Fusen Pharmaceutical
HK$0.78-10.3%-13.3%HK$576.7mn/aPS2.2xn/a0%
1011
China NT Pharma Group
HK$0.810%174.6%HK$546.1mn/aPS26.7xn/a0%
3737
Zhongzhi Pharmaceutical Holdings
HK$0.56-6.7%-41.1%HK$483.6mn/aPE21.5xn/a8.9%
1643
Modern Chinese Medicine Group
HK$0.67-5.6%42.6%HK$482.4mn/aPE23.2xn/a0%
6118
Austar Lifesciences
HK$0.94-5.1%51.6%HK$481.8mn/aPE12.5xn/a0%
897
Wai Yuen Tong Medicine Holdings
HK$0.42-6.7%90.9%HK$472.5mn/aPE66.6xn/a0%
455
Tianda Pharmaceuticals
HK$0.12-0.8%-35.1%HK$258.0mn/aPB0.5xn/a0%
8329
Shenzhen Neptunus Interlong Bio-technique
HK$0.142.2%2.9%HK$234.9mn/aPE34.7xn/a3.8%
858
Extrawell Pharmaceutical Holdings
HK$0.08811.4%63.0%HK$224.4mn/aPE1xn/an/a
8247
Biosino Bio-Technology and Science Incorporation
HK$1.42-16.5%77.5%HK$205.5mn/aPB1.3xn/a0%
1498
PuraPharm
HK$0.38-1.3%-40.6%HK$203.3mn/aPB2xn/a0%
575
Regent Pacific Group
HK$0.680%70.0%HK$198.4mn/aPS30.6xn/an/a
1312
Kontafarma China Holdings
HK$0.02911.5%-3.3%HK$162.1mn/aPB0.2xn/an/a
8225
China Health Group
HK$0.14-7.7%-10.0%HK$143.3mn/aPS4.4xn/an/a
8158
China Regenerative Medicine International
HK$0.472.2%46.9%HK$143.0mn/aPE112.8xn/an/a
1889
Sanai Health Industry Group
HK$0.50-3.8%2.0%HK$76.4mn/aPB0.2xn/an/a
Page 5 of 5